Table 1.
Patient demographics
| Patient No. | Age year | TNM | Tumoral markers | Tumor grade | Histological type of cancer |
|---|---|---|---|---|---|
| 1 | 67 | T4 N1A M0 | E90%, P90%, K10%, C1+ | II | IDC |
| 2 | 86 | T1C N1 M0 | E90%, P90%, K15%, C2+ | II | IDC |
| 3 | 80 | T1B N0 M0 | E90%, P90%, K15%, CNEG | II | IDC |
| 4 | 71 | T1C N0 M0 | ENEG, PNEG, K40%, C3+ | III | IDC |
| 5 | 75 | T2 N1 M0 | ENEG, PNEG, K30%, CNEG | III | IDC |
| 6 | 62 | T1C N0 M0 | E90%, P90%, K30%, C2+ | II | IDC |
| 7 | 84 | T4 N1 M0 | E90%, PNEG, K40%, C3+ | III | IDC |
| 8 | 76 | T2 N0 M0 | E90%, P90%, K30%, CNEG | III | IDC |
| 9 | 88 | T2 N0 M0 | E90%, P90%, K15%, C1+ | II | IDC |
| 10 | 50 | T2 N2A M0 | E90%, P90%, K20%, C2+ | III | IDC |
| 11 | 85 | T1C N1 M0 | ENEG, PNEG, K40%, CNEG | III | IDC |
| 12 | 82 | T4 N1 M0 | E90%, P40%, K20%, C3+ | II | IDC |
| 13 | 53 | T2 N2 M0 | E90%, P90%, K30%, CNEG | III | ILC |
| 14 | 68 | T2 N1 M0 | E90%, P90%, K20%, C1+ | II | IDC |
| 15 | 66 | T2 N0 M0 | E90%, P90%, K30%, C2+ | III | IDC |
| 16 | 73 | T2 N1 M0 | E80%, P70%, K20%, C3+ | II | IDC |
| 17 | 64 | T2 N0 M0 | E80%, P70%, K30%, C2+ | III | IDC |
| 18 | 63 | TIS | ENEG, PNEG, K40%, C3+ | III | ISDC |
| 19 | 47 | T2 N0 M0 | E90%, P90%, K30%, CNEG | III | IDC |
| 20 | 70 | T1C N0M0 | ENEG, PNEG, K40%, C3+ | III | IDC |
C: c-erb; E: estrogen receptor; K: Ki67; NEG: negative; P: progesteron receptor; TNM: tumor, node, metastasis; IDC: Invasive Ductal Carcinoma; ILC: Invasive Lobular Carcinoma; DCIS: In situ Ductal Carcinoma; TIS: In SituTumor.